FDA NDC Directory · JSON-LD · Markdown
NDC 25021-230 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION
| Generic name | irinotecan hydrochloride |
|---|---|
| Labeler / Manufacturer | Sagent Pharmaceuticals |
| Marketing category | Abbreviated NDA (generic) · App ANDA090675 |
| Dosage form / route | INJECTION, SOLUTION · INTRAVENOUS |
| Active ingredients | IRINOTECAN HYDROCHLORIDE (20 mg/mL) |
| Marketing started | 20140815 |
| Marketing ended | 20261031 |
| Package count | 2 |
Source: openFDA. Public-domain (CC0).